Mina Chiu is a seasoned professional in regulatory affairs, currently serving as the DRA Lead at Sandoz since 2023. Previously, they held positions including Regulatory Affairs Manager at Novo Nordisk from 2018 to 2021, RA Head of Taiwan at VISEN Pharmaceuticals from 2021 to 2022, and RA Manager at Fresenius Kabi Taiwan Ltd. from 2015 to 2018. Their foundational experience includes roles such as RA Associate Manager at Alcon and Reviewer at the Taiwan Food and Drug Administration, contributing to medical device registration and compliance. Mina earned a Bachelor's degree in Medical Technology and advanced degrees (Master's and Ph.D.) in Biological Science and Biotechnology from National Chiao Tung University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices